NV
Northpond Ventures
Venture CapitalActiveNorthpond Ventures is a science-driven project capital пђБrm that focuses on biotechnology and aпђГliated industries.
32
Investments
6
Exits
$4.5B
AUM
18.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Northpond Ventures.
Investment Thesis & Strategy
Northpond Ventures invests in biotechnology and related industries across various stages, seeking science-driven companies.
Investment Activity
Deals per year over the last 5 years
1
20191
20207
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 32 companies
A
Alumis
Biotech · Series B, 2023
E
Enliven Therapeutics
Biotech · Series B, 2022
B
Boundless Bio
Biotech · Series A, 2022
P
PathAI
AI/ML · Series C+, 2021
L
Lycia Therapeutics
Biotech · Series B, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
V
Ventyx Biosciences
Biotech · Series B, 2021
A
Aura Biosciences
Biotech · Series B, 2021
X
Xilis
Biotech · Series A, 2021
D
Deepcell
Biotech · Series A, 2021
G
Generate Biomedicines
Biotech · Series A, 2020
C
Cellarity
Biotech · Series B, 2019
Notable Exits
CompanyTypeYearValue / Acquirer
Tessera TherapeuticsAcquisition2024—
Kyverna TherapeuticsIPO2024$319M
Cabaletta BioIPO2022$200M
Lyell ImmunopharmaIPO2021$1.6B
Verve TherapeuticsIPO2021$800M
Revolution MedicinesIPO2020$2.2B
Frequently Asked Questions
Northpond Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Novak Biddle Venture Partners
Bethesda, United States · 117 deals
CNF Investments, LLC
Bethesda, United States · 45 deals
American Capital
Bethesda, United States · 31 deals
Calvert Social Venture Partners
Bethesda, United States · 12 deals
MicroVest
Bethesda, United States · 12 deals
Toucan Capital
Bethesda, United States · 8 deals